Touchstone International Medical Science688013.SHValuation Analysis

As of Oct 19, 2026, Touchstone International Medical Science (688013.SH) trades at a P/E of 35.90x, P/B of 3.68x, P/S of 8.03x, and a dividend yield of 5.74%.
Longitudinal percentile comparison: P/E sits at the 33rd percentile over the trailing 10Y window (vs. 60th percentile over 3Y); P/B sits at the 54th percentile over the trailing 10Y window (vs. 58th percentile over 3Y); P/S sits at the 46th percentile over the trailing 10Y window (vs. 55th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 48th percentile within its industry and the 48th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 6.24%, ranking at the 91st percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 21.1 points apart — worth checking the full percentile matrix on this page for the complete picture. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Of the 6.24% total shareholder yield, 5.74% is paid out as dividends and roughly 0.50% is implied to come from buybacks — both channels are meaningfully in play. Touchstone International Medical Science operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.